ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016 ACR/ARHP Annual Meeting
    • 2015 ACR/ARHP Annual Meeting
    • 2014 ACR/ARHP Annual Meeting
    • 2013 ACR/ARHP Annual Meeting
    • 2012 ACR/ARHP Annual Meeting
    • 2011 ACR/ARHP Annual Meeting
    • 2010 ACR/ARHP Annual Meeting
    • 2009 ACR/ARHP Annual Meeting
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 2663

Sense of Smell, Anti-Ribosomal P Antibodies and Neuropsychiatric Manifestations in Systemic Lupus Erythematosus

Fernando Augusto Peres1, Karina Oliveira Peliçari2, Nailu A. Sinicato1, Mariana Postal1, Aline T. Lapa1, Lilian Costallat3 and Simone Appenzeller4, 1Medicine, State University of Campinas, Campinas, Brazil, 2State University of Campinas, Campinas, Brazil, 3Medicine, State University of Campinas, Campinas, United Kingdom, 4Medicine, Faculty of Medical Science, State University of Campinas Unicamp, São Paulo, Brazil

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Antibodies, neurologic involvement and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Session Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment: Epidemiology, Women's Health, Cardiovascular and CNS

Session Type: Abstract Submissions (ACR)

Background/Purpose Neuropsychiatric manifestations occur in 12-95% of SLE patients. Recent studies have demonstrated the high specificity of antiribosomal P antibodies for SLE. Antiribosomal P antibodies are able to bind to neuronal cells in areas of the limbic system which are responsible to the olfactory. We aimed to analyze the prevalence of olfactory disorder in SLE, correlate olfactory with presence of neuropsychiatric manifestations, disease activity and the presence of antiribosomal P antibodies.

Methods Consecutive SLE patients followed at the rheumatology unit of the State University of Campinas were enrolled in this study. The control group was consisted by age and sex matched healthy individuals. A complete clinical, laboratory and neurological evaluation was performed in all subjects. Neurological manifestations were analyzed according to the ACR classification criteria. Mood and anxiety disorders were determined through Becks Depression and Becks Anxiety Inventory. SLE patients were further assessed for clinical and laboratory SLE manifestations, disease activity [SLE Disease Activity Index (SLEDAI)], damage (Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index). Anti-ribosomal P antibody was performed by Enzyme Linked Immuno Sorbent Assay. Olfactory functions were evaluated using the Sniffin’ Sticks test, in 3 stages: threshold, discrimination, and identification of different odors (TDI).

Results We included 120 SLE patients (93.3% female; mean age 40.3 years; SD±11.3 years) and 135 healthy volunteers (91.1% female; mean age 37.6 years; SD±12.4 years). Anxiety was observed in 81(67.5%) SLE patients and in 49 (39.2%) controls (p<0.001). Depression was identified in 56 (46.6%) SLE patients and in 39 (28.8%) controls (p=0.004). Anti-ribosomal P antibodies were identified exclusively in SLE patients and were present in 13 (10.8%) of them (p<0.001). Olfactory changes were observed in 62 (51.6%) SLE patients and in 40 (29.6%) controls (p=0.001). SLE patients had significantly lower mean in all phases of the olfactory assessment. The olfactory was also inversely associated with anxiety (p=0.004, R=-0.18), depression (p=0.01, R =-0.232), cumulative damage (p=0.002, R =-0.282) and age (p<0.001, R=-0.353). The TDI was correlated with a CNS involvement, and patients with NP manifestations [mean of 28.35 (SD ± 5.30)] points, whereas patients without NP manifestations had a mean TDI of 30.8 (SD ± 4.51) points (p<0.001). Antiribosomal P antibodies were not associated with CNS involvement (p=0.730), but when we analyzed each manifestation separately, we observed an association between the presence of antiribosomal P antibodies and psychosis (p<0.046). We also observed an association between antiribosomal P antibodies and disease activity (p=0.036).

Conclusion SLE patients have a significant decrease of smell when compared to healthy controls. Olfactory changes are associated with a history of neuropsychiatric symptoms, anxiety, depression, cumulative damage, and age. Antiribosomal P antibodies were exclusively observed in SLE patients compared to healthy controls and they were associated with psychosis and disease activity.


Disclosure:

F. A. Peres,
None;

K. O. Peliçari,
None;

N. A. Sinicato,
None;

M. Postal,
None;

A. T. Lapa,
None;

L. Costallat,
None;

S. Appenzeller,
None.

  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sense-of-smell-anti-ribosomal-p-antibodies-and-neuropsychiatric-manifestations-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Annual Meeting in Atlanta, Georgia

© COPYRIGHT 2019 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.